# ORPHENADRINE CITRATE
> **ANDA085046** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1982-06-29
## Drug
- **FDA Application Number:** ANDA085046
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ORPHENADRINE CITRATE
- **Generic name:** Orphenadrine Citrate
- **Active ingredients:** ORPHENADRINE CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANDOZ
- **First approval:** 1982-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085046)
---
*AI Analytics · CC0 1.0*